Insider · CIK 0001382475
John James O'Connor
Files at LMAT (LEMAITRE VASCULAR INC). First filing -, latest -.
In brief
John James O'Connor files SEC Form 4 as director at LMAT (LEMAITRE VASCULAR INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John James O'Connor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
The newest 50 of 86 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | 36 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | 36 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | 36 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | 36 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +2 | $0.00 | $0 | 4 | 36 d ago |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 3 | Jun 5, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 1 | Mar 30, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +476 | $0.00 | $0 | 62,826 | Mar 2, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +1 | $0.00 | $0 | 62,827 | Mar 2, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -1 | $0.00 | $0 | 3 | Mar 2, 2026 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +5 | $0.00 | $0 | 62,345 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +5 | $0.00 | $0 | 62,350 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -5 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -5 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +533 | $0.00 | $0 | 62,340 | Dec 11, 2025 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Stock Option (Right to Buy)derivative | +3,431 | $0.00 | $0 | 3,431 | Dec 11, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +2 | $0.00 | $0 | 61,804 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +3 | $0.00 | $0 | 61,807 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -2 | $0.00 | $0 | 4 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -3 | $0.00 | $0 | 4 | Dec 10, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | GGift Common Stock | -3,000 | $0.00 | $0 | 61,801 | Dec 8, 2025 |
| Dec 6, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +1 | $0.00 | $0 | 61,802 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 7 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 7 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Dec 8, 2025 |
| Dec 6, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -1 | $0.00 | $0 | 3 | Dec 8, 2025 |
| Nov 21, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +7,500 | $37.29 | $280k | 64,801 | Nov 21, 2025 |
| Nov 21, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 0 | Nov 21, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 7 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 3 | Sep 8, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Jun 2, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Jun 2, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Jun 2, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Jun 2, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 2 | Jun 2, 2025 |
| Mar 27, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Mar 31, 2025 |
| Mar 27, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Mar 31, 2025 |
Questions about John James O'Connor
Answered from the filings on this page, as of the latest one.
Is John James O'Connor buying or selling?
John James O'Connor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John James O'Connor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John James O'Connor has 0.
Where does John James O'Connor file Form 4?
John James O'Connor has filed Form 4 at LMAT (LEMAITRE VASCULAR INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.